These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34847492)

  • 1. Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy.
    Kamat I; Lamba H; Hines-Munson C; Hudson S; Liao K; Muldrew KL; Green S; Terwilliger A; Kaplan HB; Ramig RF; Maresso A; Trautner BW
    J Surg Res; 2022 Mar; 271():73-81. PubMed ID: 34847492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single-center descriptive experience.
    Radcliffe C; Doilicho N; Niu YS; Grant M
    Transpl Infect Dis; 2020 Oct; 22(5):e13379. PubMed ID: 32574417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center.
    Hamad Y; Blanco-Guzman MO; Olsen MA; Wang X; Vader J; Verma A; Dubberke ER
    Transpl Infect Dis; 2021 Aug; 23(4):e13686. PubMed ID: 34251073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients.
    Koval CE; Thuita L; Moazami N; Blackstone E
    J Heart Lung Transplant; 2014 Nov; 33(11):1164-72. PubMed ID: 25034793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device-related infections: a multicentric study.
    Siméon S; Flécher E; Revest M; Niculescu M; Roussel JC; Michel M; Leprince P; Tattevin P
    Clin Microbiol Infect; 2017 Oct; 23(10):748-751. PubMed ID: 28323195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and management of left ventricular assist device-associated infections.
    Nienaber JJ; Kusne S; Riaz T; Walker RC; Baddour LM; Wright AJ; Park SJ; Vikram HR; Keating MR; Arabia FA; Lahr BD; Sohail MR;
    Clin Infect Dis; 2013 Nov; 57(10):1438-48. PubMed ID: 23943820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience.
    Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M
    Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device driveline infections: recent advances and future goals.
    Leuck AM
    J Thorac Dis; 2015 Dec; 7(12):2151-7. PubMed ID: 26793335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial Reduction in Driveline Infection Rates With the Modification of Driveline Dressing Protocol.
    Lander MM; Kunz N; Dunn E; Althouse AD; Lockard K; Shullo MA; Kormos RL; Teuteberg JJ
    J Card Fail; 2018 Nov; 24(11):746-752. PubMed ID: 30098380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and prognostic impact of left ventricular assist device-associated infections.
    Tattevin P; Flécher E; Auffret V; Leclercq C; Boulé S; Vincentelli A; Dambrin C; Delmas C; Barandon L; Veniard V; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Savouré A; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bernard L; Bourguignon T; Eschalier R; D'Ostrevy N; Jouan J; Varlet E; Vanhuyse F; Blangy H; Martins RP; Galand V
    Am Heart J; 2019 Aug; 214():69-76. PubMed ID: 31174053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Durand ML; Ennis SC; Baker JN; Camuso JM; McEachern KM; Kotton CN; Lewis GD; Garcia JP; MacGillivray TE
    Artif Organs; 2017 Feb; 41(2):169-175. PubMed ID: 27098102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing driveline infections in patients supported on ventricular assist devices: a care pathway approach.
    Seretny J; Pidborochynski T; Buchholz H; Freed DH; MacArthur R; Dubyk N; Cunliffe L; Zelaya O; Conway J
    BMJ Open Qual; 2022 May; 11(2):. PubMed ID: 35649636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation.
    Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M
    Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy.
    Lumish HS; Cagliostro B; Braghieri L; Bohn B; Mondellini GM; Antler K; Feldman V; Kleet A; Murphy J; Tiburcio M; Fidlow K; Jennings D; Sayer GT; Takeda K; Naka Y; Demmer RT; Aaron JG; Uriel N; Colombo PC; Yuzefpolskaya M
    ASAIO J; 2022 Dec; 68(12):1450-1458. PubMed ID: 35239537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular implantable electronic device infections in left ventricular assist device recipients.
    Riaz T; Nienaber JJ; Baddour LM; Walker RC; Park SJ; Sohail MR
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):225-30. PubMed ID: 23998684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices.
    Akay MH; Nathan SS; Radovancevic R; Poglajen G; Jezovnik MK; Candelaria IN; Averill BL; Patel MK; Kar B; Gregoric ID
    ASAIO J; 2019; 65(7):678-682. PubMed ID: 30398982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.